DNA Topoisomerases in Cancer Therapy

Present and Future

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Health & Well Being, Medical, Specialties, Oncology
Cover of the book DNA Topoisomerases in Cancer Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461501411
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461501411
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

More books from Springer US

Cover of the book White cells and platelets in blood transfusion by
Cover of the book Impact of Natural Hazards on Oil and Gas Extraction by
Cover of the book Fundamental Phenomena in the Materials Sciences by
Cover of the book Informatics Curricula and Teaching Methods by
Cover of the book Toxic Turmoil by
Cover of the book Coping with Physical Illness by
Cover of the book Nano-Bio- Electronic, Photonic and MEMS Packaging by
Cover of the book Geochemistry of Epigenesis by
Cover of the book Lymphocyte Activation and Immune Regulation IX by
Cover of the book Supervisory Control of Discrete Event Systems Using Petri Nets by
Cover of the book Economic Policy Issues for the Next Decade by
Cover of the book The Determinants of Economic Growth by
Cover of the book Biopsy Pathology of the Bronchi by
Cover of the book Test Anxiety by
Cover of the book Social Cognitive Psychology by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy